Screener
Aquestive Therapeutics, Inc. AQST Business Segments — Other income/(expenses), net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total General and Administrative Expenses | 11,889 | 9,185 | 20,945 | 25,301 |
| Total Selling, General and Administrative Expenses | 14,063 | 12,705 | 25,040 | 31,777 |
| Total costs and expenses | 22,042 | 21,371 | 40,692 | 49,456 |
| Loss from operations | (8,223) | (11,368) | (12,427) | (30,733) |
| Other income/(expenses), net | (14,641) | (2,180) | (18,494) | (5,745) |
| Net loss before income taxes | (22,864) | (13,548) | (30,921) | (36,478) |
| Net loss | $(22,864) | $(13,548) | $(30,921) | $(36,478) |
| Comprehensive loss | $(22,864) | $(13,548) | $(30,921) | $(36,478) |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Aquestive Therapeutics, Inc.'s business segments — other income/(expenses), net?
- Aquestive Therapeutics, Inc. (AQST) reported business segments — other income/(expenses), net of -$14.64M in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s business segments — other income/(expenses), net changed year-over-year?
- Aquestive Therapeutics, Inc.'s business segments — other income/(expenses), net decreased by 571.6% year-over-year, from -$2.18M to -$14.64M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s business segments — other income/(expenses), net?
- Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s business segments — other income/(expenses), net has grown at a 30.5% compound annual growth rate (CAGR), from $7.48M to -$12.73M.
- What does business segments — other income/(expenses), net mean?
- Captures non-operating financial items such as interest income, interest expense, foreign exchange gains or losses, and other miscellaneous financial activities. This metric reflects the impact of the segment's capital structure and external financial factors on its bottom line. It is essential for distinguishing between core operational performance and peripheral financial results.
Ask your AI about Aquestive Therapeutics, Inc.'s business segments — other income/(expenses), net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude